Le diabète gestationnel dépisté précocement : beaucoup d'incertitudes

Although the increase of the fasting blood glucose is associated with an unfavorable materno-fetal prognosis, the IADPSG recently specified that it is a recommendation with currently an insufficient level of proofs. There are no randomized studies estimating the benefit of screening and an intensive care in case of early GDM. Besides, raises itself the question of the best strategy to be proposed to identify these early GDM whether it is for the test diagnosis (fasting blood glucose, OGTT, or HbA1c) or whether it is to determine the values thresholds. Thus, it is essential to acquire additional data to better characterize them, to estimate the best strategy allowing to diagnose them, and finally to demonstrate that there is a benefit to take care of them whether it is in term of materno-fetal complications but also on medico-economic. For when an HAPO early GDM study?